Royalty Pharma Plc (RPRX) earnings · P/E 33, rev $2.38B
These earnings events as JSON? API free 100/dayRoyalty Pharma Plc (RPRX) is a biotechnology company listed on US.
This RPRX earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported RPRX revenue for 2025-12-31 was $2.38B. Net income was $770.9M. Revenue was up 5.1% from 2024-12-31 to 2025-12-31. RPRX currently screens at market cap $20.45B and trailing P/E 32.6.
When the next RPRX 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 5.1% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full RPRX research stays on the stock page; the tape stays on the quote page.
RPRX earnings FAQ
What are RPRX's latest revenue and net income?
Latest cached Royalty Pharma Plc (RPRX) revenue for Dec 31, 2025 was $2.38B. Net income was $770.9M. Statements: https://lician.com/financials/rprx
What is RPRX's latest diluted EPS?
Latest cached Royalty Pharma Plc (RPRX) diluted EPS for Dec 31, 2025 was $1.78.
What period does the latest RPRX earnings print cover?
The latest cached Royalty Pharma Plc (RPRX) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did RPRX revenue change from the prior cached period?
Cached Royalty Pharma Plc (RPRX) revenue was up 5.1% from $2.26B (Dec 31, 2024) to $2.38B (Dec 31, 2025). Statements: https://lician.com/financials/rprx
What is RPRX's P/E ratio?
Royalty Pharma Plc (RPRX) trailing P/E is 32.6 on the latest cached fundamentals snapshot.
Where are RPRX earnings listed?
Cached earnings facts for Royalty Pharma Plc (RPRX) are listed at https://lician.com/earnings/rprx. Statements: https://lician.com/financials/rprx
Not investment advice.